Read More Pharma Industry News Darzalex Faspro moves closer to FDA approval as first therapy for high-risk smoldering multiple myeloma Find out how Darzalex Faspro could become the first FDA-approved therapy for high-risk smoldering multiple myeloma, reshaping early myeloma care. bySoujanya RaviNovember 7, 2025